Literature DB >> 11123370

Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.

F M Dautzenberg1, G Py-Lang, J Higelin, C Fischer, M B Wright, G Huber.   

Abstract

The binding characteristics of corticotropin-releasing factor (CRF) type 1 (CRF(1)) and type 2 (CRF(2)) receptors from human (hCRF(1) and hCRF(2alpha)) and Xenopus (xCRF(1) and xCRF(2)) were compared using four different (125)I-labeled CRF analogs, the agonists (125)I-CRF and (125)I-sauvagine, and the antagonists (125)I-astressin ((125)I-AST) and (125)I-antisauvagine-30 ((125)I-aSVG). The hCRF(2alpha) and xCRF(2) receptors bound all four radioligands with different affinities, whereas hCRF(1) did not bind (125)I-aSVG, and xCRF(1) bound neither (125)I-sauvagine nor (125)I-aSVG. Competitive binding studies using unlabeled agonists and antagonists with hCRF(1) and hCRF(2alpha) receptors revealed that most agonists exhibited higher affinity in displacing agonist radioligands compared with displacement of antagonist radioligands. Exceptions were the agonists human and rat urocortin, which displayed high-affinity binding in the presence of either (125)I-labeled agonist or antagonist ligands. In contrast, the affinities of antagonists were independent of the nature of the radioligand. We also found that, in contrast to the mammalian CRF receptors, the affinity of ligand binding to xCRF(1) and xCRF(2) receptors strongly depended on the nature of the radioligand used for competition. For xCRF(1), competitors showed different rank order binding profiles with (125)I-CRF compared with (125)I-AST as the displaceable ligand. Similarly, binding of competitors to the xCRF(2) receptor showed markedly different profiles with (125)I-CRF as the competed ligand compared with the other radioligands. These data demonstrate that amphibian CRF receptors have distinctly different binding modes compared with their mammalian counterparts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123370

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

2.  Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.

Authors:  Shunske Tanahashi; Satoshi Yamamura; Masanori Nakagawa; Eishi Motomura; Motohiro Okada
Journal:  Psychopharmacology (Berl)       Date:  2011-09-27       Impact factor: 4.530

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Basolateral amygdala corticotropin-releasing factor receptor type 1 regulates context-cocaine memory strength during reconsolidation in a sex-dependent manner.

Authors:  Jobe L Ritchie; Jennifer L Walters; Justine M C Galliou; Robert J Christian; Shuyi Qi; Marina I Savenkova; Christopher K Ibarra; Shayna R Grogan; Rita A Fuchs
Journal:  Neuropharmacology       Date:  2021-10-02       Impact factor: 5.250

5.  Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.

Authors:  Victoria B Risbrough; Richard L Hauger; Amanda L Roberts; Wylie W Vale; Mark A Geyer
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

6.  Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.

Authors:  Eric Gutknecht; Richard L Hauger; Ilse Van der Linden; Georges Vauquelin; Frank M Dautzenberg
Journal:  J Neurochem       Date:  2007-11-01       Impact factor: 5.372

7.  The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.

Authors:  A J Lawrence; E V Krstew; F M Dautzenberg; A Rühmann
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

8.  Differential blockade of CRF-evoked behaviors by depletion of norepinephrine and serotonin in rats.

Authors:  Owen Howard; Gregory V Carr; Tiffany E Hill; Rita J Valentino; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2008-05-31       Impact factor: 4.530

9.  Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function.

Authors:  D Wootten; H Lindmark; M Kadmiel; H Willcockson; K M Caron; J Barwell; T Drmota; D R Poyner
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.

Authors:  Zoe Tasma; Peter Wills; Debbie L Hay; Christopher S Walker
Journal:  Pharmacol Res Perspect       Date:  2020-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.